Key facts
- A clinical trial for an Ebola treatment has begun in the Democratic Republic of Congo.
- The trial will evaluate the effectiveness of remdesivir.
- The trial will evaluate the effectiveness of MBP134.
- The trial is testing treatments against the Bundibugyo virus.
- The trial commences amidst mourning for hundreds of Ebola victims.
A clinical trial for an Ebola treatment has commenced in the Democratic Republic of Congo. The study is designed to evaluate the effectiveness of two specific drugs, remdesivir and MBP134, against the Bundibugyo virus. This development arrives as the nation continues to mourn hundreds of victims of the ongoing Ebola outbreak. The trial represents a significant effort to find viable treatments for the deadly disease.